| 1 |
33088647 | Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes. | 2020 Oct |
1 |
| 2 |
30636597 | Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis. | 2019 |
2 |
| 3 |
31129789 | Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug-Drug-Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole. | 2019 Dec |
2 |
| 4 |
28653144 | Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis. | 2018 Apr |
1 |
| 5 |
29748863 | Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population. | 2018 Aug |
5 |
| 6 |
30260092 | A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study. | 2018 Dec |
1 |
| 7 |
28479356 | Quantitative Analysis of Complex Drug-Drug Interactions Between Repaglinide and Cyclosporin A/Gemfibrozil Using Physiologically Based Pharmacokinetic Models With In Vitro Transporter/Enzyme Inhibition Data. | 2017 Sep |
2 |
| 8 |
27457785 | Clarification of the Mechanism of Clopidogrel-Mediated Drug-Drug Interaction in a Clinical Cassette Small-dose Study and Its Prediction Based on In Vitro Information. | 2016 Oct |
2 |
| 9 |
27543206 | Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics. | 2016 Nov |
1 |
| 10 |
24623479 | Reduced physiologically-based pharmacokinetic model of repaglinide: impact of OATP1B1 and CYP2C8 genotype and source of in vitro data on the prediction of drug-drug interaction risk. | 2014 Sep |
4 |
| 11 |
24971633 | Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions. | 2014 Oct |
1 |
| 12 |
23393219 | Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin. | 2013 May |
1 |
| 13 |
23625433 | Effect of pitavastatin in different SLCO1B1 backgrounds on repaglinide pharmacokinetics and pharmacodynamics in healthy Chinese males. | 2013 May |
3 |
| 14 |
23153186 | CYP2C metabolism of oral antidiabetic drugs--impact on pharmacokinetics, drug interactions and pharmacogenetic aspects. | 2012 Dec |
1 |
| 15 |
21327909 | Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers. | 2011 Jul |
5 |
| 16 |
22041697 | [Genetic polymorphisms of SLCO1B1 for drug pharmacokinetics and its clinical implications]. | 2011 |
3 |
| 17 |
20406215 | SLCO1B1 polymorphism and oral antidiabetic drugs. | 2010 Oct |
5 |
| 18 |
19785645 | Impact of OATP transporters on pharmacokinetics. | 2009 Oct |
1 |
| 19 |
17923851 | Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism. | 2008 Aug |
1 |
| 20 |
18187595 | Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide. | 2008 Mar |
2 |
| 21 |
18823304 | The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range. | 2008 Dec |
3 |
| 22 |
18854776 | Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide. | 2008 Nov |
7 |
| 23 |
19238654 | Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism. | 2008 Oct |
5 |
| 24 |
16796707 | Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide. | 2006 Nov |
4 |
| 25 |
16198658 | Cyclosporine markedly raises the plasma concentrations of repaglinide. | 2005 Oct |
3 |